161 related articles for article (PubMed ID: 22423979)
1. BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control.
Stefansson OA; Esteller M
Breast Cancer Res; 2012 Mar; 14(2):304. PubMed ID: 22423979
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.
Catteau A; Harris WH; Xu CF; Solomon E
Oncogene; 1999 Mar; 18(11):1957-65. PubMed ID: 10208417
[TBL] [Abstract][Full Text] [Related]
3. The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression.
Chang S; Sharan SK
Transcription; 2013; 4(1):24-8. PubMed ID: 23131665
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of BRCA1 tumor suppression.
Silver DP; Livingston DM
Cancer Discov; 2012 Aug; 2(8):679-84. PubMed ID: 22843421
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation and microRNA patterns are in association with the expression of BRCA1 in ovarian cancer.
Shariati-Kohbanani M; Zare-Bidaki M; Taghavi MM; Taghipour Z; Shabanizadeh A; Kennedy D; Dahim H; Salahshoor MR; Jalili C; Kazemi Arababadi M
Cell Mol Biol (Noisy-le-grand); 2016 Jan; 62(1):16-23. PubMed ID: 26828981
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Patterns of
Arakelyan A; Melkonyan A; Hakobyan S; Boyarskih U; Simonyan A; Nersisyan L; Nikoghosyan M; Filipenko M; Binder H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525353
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
Zhu Q; Pao GM; Huynh AM; Suh H; Tonnu N; Nederlof PM; Gage FH; Verma IM
Nature; 2011 Sep; 477(7363):179-84. PubMed ID: 21901007
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 regulation of transcription.
Rosen EM; Fan S; Ma Y
Cancer Lett; 2006 May; 236(2):175-85. PubMed ID: 15975711
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses.
Wang Z; Zhang J; Zhang Y; Deng Q; Liang H
Int J Mol Med; 2018 Dec; 42(6):3542-3550. PubMed ID: 30221688
[TBL] [Abstract][Full Text] [Related]
10. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
Buckley NE; D'Costa Z; Kaminska M; Mullan PB
Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
[TBL] [Abstract][Full Text] [Related]
11. The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.
Elledge SJ; Amon A
Cancer Cell; 2002 Mar; 1(2):129-32. PubMed ID: 12086871
[No Abstract] [Full Text] [Related]
12. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.
Ibrahim N; He L; Leong CO; Xing D; Karlan BY; Swisher EM; Rueda BR; Orsulic S; Ellisen LW
Cancer Res; 2010 Sep; 70(18):7155-65. PubMed ID: 20807817
[TBL] [Abstract][Full Text] [Related]
13. Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
Press JZ; De Luca A; Boyd N; Young S; Troussard A; Ridge Y; Kaurah P; Kalloger SE; Blood KA; Smith M; Spellman PT; Wang Y; Miller DM; Horsman D; Faham M; Gilks CB; Gray J; Huntsman DG
BMC Cancer; 2008 Jan; 8():17. PubMed ID: 18208621
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures.
Hedenfalk IA
J Natl Cancer Inst; 2002 Jul; 94(13):960-1. PubMed ID: 12096075
[No Abstract] [Full Text] [Related]
15. Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer.
Hansmann T; Pliushch G; Leubner M; Kroll P; Endt D; Gehrig A; Preisler-Adams S; Wieacker P; Haaf T
Hum Mol Genet; 2012 Nov; 21(21):4669-79. PubMed ID: 22843497
[TBL] [Abstract][Full Text] [Related]
16. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 methylation: a significant role in tumour development?
Catteau A; Morris JR
Semin Cancer Biol; 2002 Oct; 12(5):359-371. PubMed ID: 12191635
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and microRNAs: emerging networks and potential therapeutic targets.
Chang S; Sharan SK
Mol Cells; 2012 Nov; 34(5):425-32. PubMed ID: 22936386
[TBL] [Abstract][Full Text] [Related]
20. The role of BRCA1 in DNA damage response.
Wu J; Lu LY; Yu X
Protein Cell; 2010 Feb; 1(2):117-23. PubMed ID: 21203981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
